Stewart Craig

Stewart Craig has a diverse work experience spanning over two decades. Stewart is currently working as a Scientific Consultant at Invivyd since March 2021. Prior to this, they served as the Director of Vector Core at Affinia Therapeutics from October 2019 to March 2021.

Before joining Affinia Therapeutics, Stewart worked at Ultragenyx Pharmaceutical Inc. for five years. Stewart held various roles, including Head of Molecular Core Operations from August 2018 to October 2019, Scientist II from July 2018 to October 2019, Scientist I from July 2016 to July 2018, and Sr. Research Associate from May 2014 to July 2016.

Stewart's earlier work experience includes being a Scientific Associate at Novartis Vaccines and Diagnostics from January 2011 to May 2014. Stewart also served as a Research Technologist at Boston Children's Hospital from April 2005 to December 2010 and as an Instructor in Microbiology at Cambridge College from February 2010 to June 2010.

Their career began at Dana-Farber Cancer Institute, where they worked as a Research Technician from July 2000 to April 2005. Stewart Craig has gained extensive experience and expertise throughout their professional journey in the scientific field.

Stewart Craig earned a Bachelor of Science degree in Immunology from the University of Glasgow, completing their studies from 1996 to 2000. Stewart then pursued further education at the same university, obtaining a Doctor of Education (EdD) degree in Analytic Philosophy from 2006 to 2013.